COVID-19 Vaccines Holding Up Well Against Delta Virus Variant, but Protection Waning in Elderly: Studies

COVID-19 Vaccines Holding Up Well Against Delta Virus Variant, but Protection Waning in Elderly: Studies
A nurse prepares a Pfizer BioNTech COVID-19 vaccination in Los Angeles, Calif., on Aug. 23, 2021. Lucy Nicholson/Reuters
Zachary Stieber
By Zachary Stieber, Senior Reporter
Updated:

The two main COVID-19 vaccines used in the United States are still protecting well against hospitalization and death, even with a new variant of the virus that causes COVID-19 circulating, a trio of new studies out Friday show.

At the same time, the effectiveness of the vaccines is down for the elderly, and the Johnson & Johnson jab showed much lower protection than the others, researchers found. And people who are not fully vaccinated have a much higher risk of needing hospital care or dying with COVID-19, the disease caused by the CCP (Chinese Communist Party) virus, the studies indicated.
Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics